ESR1 and metabolic syndrome: The microarray shows secretion patterns of 10 biomarkers after exposure to estrogen receptor agonists and antagonists, and provides indications for their involvement in: estrogen receptor interaction, steroid synthesis, cancer, metabolic syndrome, and reproductive and developmental processes.